Objective 
Introduction:
Dengue infection is endemic in many countries along the tropical and subtropical belt, with more than 100 million cases and 24,000 deaths annually. In humans Dengue Virus (DENV) infection leads to a spectrum of clinical manifestations that range from inapparent or mild febrile illness as dengue fever (DF) to severe and fatal haemorrhagic disease as dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS). 1 The etiologic agent (DENV) belongs to the Flaviviridae family and to the Flavivirus genus, with 4 serotypes.
The symptomatology of dengue varies, generally consisting of the mild forms found in cases of classic dengue, the principal manifestations of which are high fever, arthralgias, myalgias, cephalea and gastrointestinal disorders. AST and ALT are liver enzymes involved in amino acid metabolism. Hepatic dysfunction is common in dengue infection, and is attributed to a direct viral effect on liver cells or as a consequence of dysregulated host immune responses against the virus. 1
In view of the wide range of symptomatology, the diagnosis of dengue should be based both on clinical J MEDICINE 2008; 9 : 66-68 .
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and laboratory data. Complementary investigations aid in evaluating the severity of the disease and the complications resulting from this pathology. Virus isolation is the most specific laboratory test for the diagnosis of dengue. Blood sample should be collected prior to the 6th day of symptoms, the viremic period. Immunoenzymatic tests (ELISA) are an alternative for confirmation of the diagnosis and are available in the laboratories of the public healthcare network. These tests permit confirmation in samples taken from the 7th day of the disease onwards in around 80% of cases, achieving as high as 100% of cases after two weeks. 2 In the present study, the enzymatic method was used during an epidemic of dengue from March 2006 to July 2006 at Mitford hospital.
Materials and Methods:
A total of 100 patients receiving care at Mitford Hospital for Diagnosis and Treatment of dengue were included in this study between March and July 2006. Dengue was suspected when two or more of the following symptoms were present: fever, cephalea, retroorbital pain, myalgias, arthralgias, skin rash, nausea, vomiting, prostration and hemorrhagic manifestations. Patients were hospitalized in accordance with the standard protocol of the institute during the period in which symptoms were present or while laboratory tests remained abnormal.
The diagnosis of DHF was established according to the World Health Organization (WHO) criteria: thrombocytopenia <100,000/mm3, hemoconcentration and hemorrhagic manifestations such as spontaneous petechiae, or a positive tourniquet test. Hemoconcentration was defined as hematocrit >45% in men, >40% in women and >38% in children under 12 years of age. The criterion of a 20% increase in hematocrit was not applicable for this study population because in the majority of cases, previous, recently performed blood counts were not available for comparison.
Tests for the detection of anti-dengue antibodies were carried out in blood samples collected between the 7 th and 11 th day following the onset of symptoms. These samples were simultaneously submitted to two serological tests: immunoenzymatic assay IgMDengue-Biomanguinhos and immunoenzymatic assay IgM-Dengue-PanBio, in accordance with the manufacturer's instructions. When the results of both tests were positive, patients were considered to be currently infected by the dengue virus, while cases in which the results of both samples were negative were considered unconfirmed. Immunoenzymatic assay IgG-Dengue is also done in every cases.
The degree to which the liver was affected was evaluated in these patients and classified into four groups according to AST and ALT levels during the period of infection. The laboratory reference values of AST and ALT for males were 59 UI/L and 72 UI/ L, respectively, and for women reference values were 36 IU/L and 52 IU/L, respectively. Grade A comprised patients with normal AST and ALT levels. Grade B was composed of patients in whom the level of at least one of the aminotransferases was increased but not higher than three times of the normal value. When the values of at least one of the enzymes were more than 3 but less than 10 times of the reference values, patients were classified as Grade C. Patients in whom there was an increase in one or both enzymes to levels more than or equal to 10 times of the reference values were classified as Grade D, thereby defining the presence of hepatitis caused by DENV. In this study, the patients with increased aminotransferases greater than 10 times of the reference values were tested for hepatitis viruses A, B and C (ELISA technique). In cases in which a diagnosis of dengue was eliminated, other diagnostic possibilities were investigated on an individual, case by case basis.
Results:
Only serologically proven cases of Dengue patients were included in the study. Dengue was confirmed in 100 cases by both immuno-enzymatic tests. Of these, 58 patients (58%) were female and 42 (42%) were male. Mean age of patients was 34.5 years (range 7-78 years). A total of 70 cases (70%) were classified as classic dengue and 30 (30%) as DHF (Table I) . No changes in aminotransferases were detected in 34% of the population studied, (Grade A), where as aminotransferase levels were high in 66% of patients, 44% classified as Grade B, 20% as Grade C and 2% as Grade D. In the cases classified as classic dengue, aminotransferases were high in 62%, while in cases of DHF, aminotransferases were abnormal in 74% of cases. Anti Dengue-IgG was positive in 23 cases (Table I) . 
Discussion:
The extent to which the liver is affected by DENV ranges from mild lesions to fulminant hepatitis. 3, [4] [5] [6] [7] [8] Liver involvement may be characterized by manifestations such as pain in the right hypochondrium, hepatomegaly varying degrees of jaundice 9 ,and an increase in liver markers, principally ALT and AST, similar to those found in acute hepatitis caused by the A, B, C, D and E viruses. In this study, patients with aminotransferase levels more than 10 times of the reference values, had negative results for hepatitis A, B, C and E according to ELISA technique.
In a study carried out in Bangkok, 6 104 patients with a clinical and serological diagnosis of dengue were classified according to severity into: classic dengue, dengue hemorrhagic fever and dengue shock syndrome. Liver function tests showed that the most severely ill patients had higher levels of aminotransferases. In children, 74% had hepatomegaly, and aminotransferase and alkaline phosphatase levels were between 80 and 87% higher compared to normal value. Therefore, AST, ALT are valuable parameters for the evaluation of the severity of the infection. In a study carried out by Nguyen et al. 10 , AST values were reported to be frequently abnormal, reaching values higher than those of ALT, around 97.7% and 37.3% above normal levels, respectively. Anti Dengue IgG was present in 23% cases.
Conclusion:
Dengue is normally associated with a moderate increase in aminotransferases and, less frequently, acute hepatitis. In this present study, liver damage was more frequent among women, in patients with a primary infection and in those with DHF. In all the cases observed, dengue was found to be self limiting, and there were no cases of liver failure. DENV may, therefore, provoke varying degrees of damage to the hepatic parenchyma, ranging from mild increases in aminotransferases to increases up to 30 times of the reference values. Therefore, the use of liver tests to evaluate the degree of liver damage is of great importance, and markers such as AST and ALT may be used as parameters to evaluate severity. In complicated classic dengue, dengue hemorrhagic fever and in dengue shock syndrome, concomitant deficiency of coagulation factors and thrombocytopenia should be considered in the pathophysiology of the disease as factors that tend to aggravate hemorrhagic status.
